Ticker League

EBITDA for Thermo Fisher Scientific (TMO)

Latest filings through · Reported

Metric

TTM

$11.16B

YoY change

-2.8%

5Y CAGR

+2.6%

Peak year (2021)

$11.97B

EBITDA history chart for Thermo Fisher Scientific (TMO) from 1985 to 2025

Latest: $11.47B

EBITDA growth chart for Thermo Fisher Scientific (TMO) from 1985 to 2025

Latest: -2.8%

EBITDA history table for Thermo Fisher Scientific (TMO) from 1985 to 2025

  • 2025$11.47B-2.8%
  • 2024$11.80B+5.4%
  • 2023$11.20B-6.3%
  • 2022$11.94B-0.2%
  • 2021$11.97B+18.4%
  • 2020$10.11B+43.9%
  • 2019$7.02B+13.4%
  • 2018$6.20B+22.6%
  • 2017$5.05B+18.9%
  • 2016$4.25B+5.2%
  • 2015$4.04B-5.0%
  • 2014$4.25B+64.7%
  • 2013$2.58B+3.5%
  • 2012$2.49B+14.2%
  • 2011$2.18B+14.2%
  • 2010$1.91B+4.3%
  • 2009$1.83B-11.6%
  • 2008$2.07B+16.6%
  • 2007$1.78B+254.1%
  • 2006$502.07M+15.2%
  • 2005$435.88M+29.6%
  • 2004$336.34M+20.4%
  • 2003$279.30M+44.7%
  • 2002$193.08M-27.3%
  • 2001$265.43M-10.2%
  • 2000$295.65M-18.4%
  • 1999$362.20M+2.5%
  • 1998$353.40M-4.9%
  • 1997$371.60M-7.0%
  • 1996$399.40M+20.2%
  • 1995$332.30M+37.3%
  • 1994$242.10M+45.8%
  • 1993$166.00M+70.3%
  • 1992$97.50M+58.0%
  • 1991$61.70M+13.4%
  • 1990$54.40M+78.4%
  • 1989$30.50M+0.7%
  • 1988$30.30M+72.2%
  • 1987$17.60M-15.0%
  • 1986$20.70M+63.0%
  • 1985$12.70M—

EBITDA values are taken from Thermo Fisher Scientific's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA at Thermo Fisher Scientific (TMO)

According to Thermo Fisher Scientific's latest reported financial statements, the company's current EBITDA (TTM) is $11.16B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Thermo Fisher Scientific (TMO) EBITDA is $11.47B – edged down 2.8% year-over-year.

Thermo Fisher Scientific EBITDA has grown on net over the period, with a +2.6% compound annual growth rate over 2020–2025 (5 years).

Between 2021 and 2025, Thermo Fisher Scientific EBITDA edged down 4.2%, falling from $11.97B to $11.47B.

2021 marks the peak EBITDA at $11.97B, with the historical low of $12.70M recorded in 1985.

Thermo Fisher Scientific EBITDA by Year

Thermo Fisher Scientific EBITDA 2025: $11.47B

In 2025, Thermo Fisher Scientific reported EBITDA of $11.47B, edged down 2.8% below 2024.

Thermo Fisher Scientific EBITDA 2024: $11.80B

Thermo Fisher Scientific EBITDA in 2024 was $11.80B, grew 5.4% from 2023.

Thermo Fisher Scientific EBITDA 2023: $11.20B

2023's EBITDA for Thermo Fisher Scientific came in at $11.20B, declined 6.3% below 2022.

Thermo Fisher Scientific EBITDA 2022: $11.94B

Thermo Fisher Scientific posted EBITDA of $11.94B in 2022, edged down 0.2% below 2021.

Thermo Fisher Scientific EBITDA 2021: $11.97B

Thermo Fisher Scientific EBITDA in 2021 was $11.97B.

See more financial history for Thermo Fisher Scientific (TMO).

Sector peers by EBITDA

Healthcare peers of Thermo Fisher Scientific (TMO), ranked by their latest EBITDA

Frequently asked questions

Thermo Fisher Scientific (TMO) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview